Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

Related Citations for PubMed (Select 19782074)

1.

The brain RAS and Alzheimer's disease.

Wright JW, Harding JW.

Exp Neurol. 2010 Jun;223(2):326-33. doi: 10.1016/j.expneurol.2009.09.012. Epub 2009 Sep 24. Review.

PMID:
19782074
2.

Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression.

Gard PR.

Expert Opin Ther Targets. 2004 Feb;8(1):7-14. Review.

PMID:
14996614
3.

Angiotensins in Alzheimer's disease - friend or foe?

Kehoe PG, Miners S, Love S.

Trends Neurosci. 2009 Dec;32(12):619-28. doi: 10.1016/j.tins.2009.07.006. Epub 2009 Sep 30. Review.

PMID:
19796831
4.
5.

Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.

Fournier A, Oprisiu-Fournier R, Serot JM, Godefroy O, Achard JM, Faure S, Mazouz H, Temmar M, Albu A, Bordet R, Hanon O, Gueyffier F, Wang J, Black S, Sato N.

Expert Rev Neurother. 2009 Sep;9(9):1413-31. doi: 10.1586/ern.09.89. Review.

PMID:
19769454
6.

RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.

Werner C, Baumhäkel M, Teo KK, Schmieder R, Mann J, Unger T, Yusuf S, Böhm M.

Clin Res Cardiol. 2008 Jul;97(7):418-31. doi: 10.1007/s00392-008-0668-3. Epub 2008 May 3. Review.

PMID:
18454336
7.

The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease.

Wright JW, Harding JW.

J Renin Angiotensin Aldosterone Syst. 2008 Dec;9(4):226-37. doi: 10.1177/1470320308099084. Review.

PMID:
19126664
8.
9.

Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease.

Ashby EL, Kehoe PG.

Expert Opin Investig Drugs. 2013 Oct;22(10):1229-42. doi: 10.1517/13543784.2013.812631. Epub 2013 Jun 26. Review.

PMID:
23800077
10.

Angiotensin receptor blockers: evidence for preserving target organs.

Carson P, Giles T, Higginbotham M, Hollenberg N, Kannel W, Siragy HM.

Clin Cardiol. 2001 Mar;24(3):183-90.

PMID:
11288962
11.

Recent changes in the landscape of combination RAS blockade.

Epstein BJ, Smith SM, Choksi R.

Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1373-84. doi: 10.1586/erc.09.127. Review.

PMID:
19900020
12.

[Therapy of Alzheimer disease].

Kovács T.

Neuropsychopharmacol Hung. 2009 Mar;11(1):27-33. Review. Hungarian.

13.

Inhibition of the renin-angiotensin system and the prevention of stroke.

Schrader J, Kulschewski A, Dendorfer A.

Am J Cardiovasc Drugs. 2007;7(1):25-37.

PMID:
17355164
14.

Angiotensin and Alzheimer's disease: therapeutic prospects.

Gard PR, Rusted JM.

Expert Rev Neurother. 2004 Jan;4(1):87-96. Review.

PMID:
15853619
15.

The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: new therapeutic potential.

Takeda S, Sato N, Ogihara T, Morishita R.

Front Biosci. 2008 Jan 1;13:2253-65. Review.

PMID:
17981707
16.
17.

Development of inhibitors of the aspartyl protease renin for the treatment of hypertension.

Scott BB, McGeehan GM, Harrison RK.

Curr Protein Pept Sci. 2006 Jun;7(3):241-54. Review.

PMID:
16787263
18.

The renin angiotensin system and Alzheimer's disease.

Amouyel P, Richard F, Berr C, David-Fromentin I, Helbecque N.

Ann N Y Acad Sci. 2000 Apr;903:437-41.

PMID:
10818534
19.

Angiotensin II type 1 receptor blockade: high hopes sent back to reality?

Grothusen A, Divchev D, Luchtefeld M, Schieffer B.

Minerva Cardioangiol. 2009 Dec;57(6):773-85. Review.

PMID:
19942847
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk